For decades, doctors and researchers have pointed to the Mediterranean Diet as the gold standard of healthy eating. Study after study confirmed what populations across Greece, Italy, and Spain seemed to live out naturally: eat this way, and you will likely live longer, think more clearly, and age with far greater physical resilience than your peers. The science was consistent. The evidence was vast. Yet one question kept slipping through the cracks of every peer-reviewed study and clinical report. Nobody could say, with precision and proof, exactly why it worked.
DailyColours believes it has the answer. And the company has the patents to back it up.
The Mechanism Nobody Could Name
The team at DailyColours spent four years building a scientific case around a thesis that sounds almost too simple once you hear it. The secret to the Mediterranean Diet, they argue, is not the olive oil or the fish or the absence of processed sugar. It is the colour.
Colour pigments in fruits, vegetables, and herbs are not merely aesthetic. They are biochemically active nutrients. Beta carotene in carrots is the most familiar example, but it represents only a fraction of what DailyColours’ research identified. When plant foods from five distinct colour groups, red, green, blue-purple, orange-yellow, and their associated phytonutrients, are consumed together, they produce a synergistic effect on the body that no single colour group can replicate alone. The whole, the research concluded, is dramatically more potent than the sum of its parts.
That finding earned DailyColours multiple international patents, a rare achievement for any natural health supplement. Patent authorities do not award intellectual property protection for ideas already known to science. The recognition signals that the company identified something genuinely original: the biochemical basis for benefits that medicine had documented for generations but never fully traced to their source.
The company was co-founded by Hartley Pond, a senior executive from VDF/Futureceuticals, one of the world’s leading suppliers of phytonutrient ingredients, and Carl Randall, a food and nutrition executive with an MBA from Wharton and over four decades of industry experience. Their scientific collaborator, Colin Rose BSc, a Senior Associate of the Royal Society of Medicine, Fellow of the Royal Society of Arts, and author of Delay Aging: Healthy to 100, served as Development Partner, shaping the nutritional science framework that sits at the product’s core.
From Clinical Theory to Measurable Results
A thesis, however elegant, still has to survive clinical scrutiny. DailyColours submitted its formula to trials at two of Britain’s most respected academic institutions: King’s College London and the University of Exeter. The results cleared the bar that most supplement brands never attempt to reach.
Trial participants recorded “significant improvements in cognitive performance” and “significant improvements in physical fitness outcomes.” A clinical trial summary went further, concluding that DailyColours “mimics the Mediterranean Diet”, a phrase that carries considerable scientific weight given the diet’s decades of supporting research. These were not anecdotal reports from consumers. They were measured outcomes produced under controlled academic conditions.
DailyColours packs 161 nutrients derived from Mediterranean plant sources into a single daily supplement. The formulation draws from each of the five colour groups, and the proportions were shaped by years of testing before the clinical trials even began. Participants in those trials reported excellent feedback, and the product has since earned the support of NCIM, the National Centre for Integrative Medicine, an institution that does not align itself lightly with commercial health products.
A New Category in an Overcrowded Market
The healthy aging supplement sector is loud and crowded. Elysium, Novos, and Donotage each occupy space in a market built largely on single-compound theories: one molecule, one pathway, one promised outcome. The appeal of that model is its simplicity. The problem, DailyColours contends, is that it does not reflect how the human body actually ages or how nutrition actually protects it.
DailyColours was built on a different premise. Healthy aging, the company argues, is not a problem that yields to a single compound. It responds to the kind of broad, plant-rich, colour-saturated eating that Mediterranean populations have practiced for generations. What the research did was take that pattern, identify its operative mechanism, and reproduce it in a form that requires no meal planning, no access to a Mediterranean market, and no complete dietary overhaul.
The product goes on sale in the United Kingdom on May 11th, with US expansion anticipated within the next 12 months. What Pond, Randall, and Rose are bringing to market is not simply a new supplement. They are staking a claim on an entirely new category, one they have named colour nutrition, grounded in clinical evidence and protected by international patent law. Nutritional science spent decades celebrating the Mediterranean Diet. DailyColours spent four years figuring out what made it work. The answer, it turns out, was visible the entire time.